欧盟 - 冰岛文 - EMA (European Medicines Agency)

amgen europe bv - sotorasib - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.

欧盟 - 冰岛文 - EMA (European Medicines Agency)

astellas pharma europe b.v. - enfortumab vedotin - carcinoma, transitional cell; urologic neoplasms - Æxlishemjandi lyf - padcev as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a platinum-containing chemotherapy and a programmed death receptor 1 or programmed death ligand 1 inhibitor.

欧盟 - 冰岛文 - EMA (European Medicines Agency)

novartis europharm limited - asciminib hydrochloride - kyrningahvítblæði, mergbreytilegt, langvinnt, bcr-abl jákvætt - Æxlishemjandi lyf - scemblix is indicated for the treatment of adult patients with philadelphia chromosome positive chronic myeloid leukaemia in chronic phase (ph+ cml cp) previously treated with two or more tyrosine kinase inhibitors (see section 5.

欧盟 - 冰岛文 - EMA (European Medicines Agency)

takeda pharmaceuticals international ag ireland branch - maribavir - cytomegalovirus sýkingar - veirueyðandi lyf til almennrar notkunar - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). Íhuga ætti að opinbera leiðsögn á réttri notkun af veirum.

欧盟 - 冰岛文 - EMA (European Medicines Agency)

mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.

欧盟 - 冰岛文 - EMA (European Medicines Agency)

agios netherlands b.v. - mitapivat sulfate - genetic diseases, inborn; anemia, hemolytic - other hematological agents - pyrukynd is indicated for the treatment of pyruvate kinase deficiency (pk deficiency) in adult patients (see section 4.

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

orion corporation - diltiazemum hýdróklóríð - forðatafla - 120 mg

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

stada arzneimittel ag - aprepitantum inn - hart hylki - 125 mg/80 mg

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

abcur ab - thiopentalum natricum inn - stungulyfsstofn, lausn - 1 g

冰岛 - 冰岛文 - LYFJASTOFNUN (Icelandic Medicines Agency)

baxter medical ab* - desfluranum inn - innöndunargufa, gegndreyptur stabbi